C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
11/2001
11/20/2001	US6319946 Inhibitors of aspartyl protease
11/20/2001	US6319940 Carbanilides used as pesticides
11/20/2001	US6319930 Substituted dimeric compounds
11/20/2001	US6319428 Perfluorinated amide salts and their uses as ionic conducting materials
11/15/2001	WO2001085712A1 Method for the preparation of citalopram
11/15/2001	WO2001085711A1 Method for the production of l-ascorbic acid by lactonisation of 2-keto-l-gulonic acid or 2-keto-l-gulonate esters
11/15/2001	WO2001085710A1 Novel anticancer compounds: process for their preparation and pharmaceutical compositions containing them
11/15/2001	WO2001085709A2 New compounds having anticancer activity: process for their preparation and pharmaceutical compositions containing them
11/15/2001	WO2001085708A1 Method for distillative separation of mixtures containing tetrahydrofuran, $g(g)-butyrolactone and/or 1,4-butanediol
11/15/2001	WO2001085694A2 Substituted diamide derivatives useful as motilin antagonists
11/15/2001	WO2001085683A2 Pyrrolyl-, furanyl- and thienyl-substituted p-aminophenols and colorants containing said compounds
11/15/2001	WO2001085664A2 Compounds and methods for regulating bacterial growth and pathogenesis
11/15/2001	US20010041814 Phthalic acid diamide derivatives fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
11/15/2001	US20010041728 With thiourea, thioamide, or dithiocarbamate functionality; (S)-N-(((3-(3-fluoro-4-morpholinyl)phenyl)-2-oxo-5 -oxazolidinyl)methyl)thioacetamide for example; treats multiple-resistant staphylococci
11/15/2001	US20010041715 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
11/15/2001	US20010041705 Heterocyclic carboxamides
11/15/2001	DE10022518A1 Preparation of L-ascorbic acids by reacting 2-keto-L-gulonic acids or melt of 2-keto-L-gulonic acid alkyl esters under acid catalysis using water-miscible solvent(s)
11/15/2001	CA2408288A1 Novel substituted diamine derivatives useful as motilin antagonists
11/14/2001	EP1153917A1 p-Aminophenol derivatives and colorants containing them
11/14/2001	EP1152826A1 Phosphorus/vanadium maleic anhydride catalyst preparation
11/14/2001	CN1322308A Colour photographic material
11/14/2001	CN1322204A Oxazolidinone antibacterial agents having thiocarbonyl functionality
11/14/2001	CN1322151A Selective oxidation process and catalyst therefor
11/14/2001	CN1074765C Process for preparing 3-(1-hydroxypheny1-1-alkoximinomethyl) dioxazines
11/13/2001	US6316640 Preparation of tetrahydrofuran
11/13/2001	US6316487 For therapy of ventricular tachyarrhythmias, especially in patients with congestive heart failure and ventricular arrhythmias and supraventricular arrhythmias, including atrial fibrillation and re-entrant tachyarrhythmias
11/13/2001	US6316486 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/13/2001	US6316450 Compounds
11/13/2001	US6316439 Galanthamine derivatives as acetylcholinesterase inhibitors
11/13/2001	US6315884 Method for producing phthalides
11/08/2001	WO2001083488A1 Improved synthesis of anhydroglycitol esters of improved colour
11/08/2001	WO2001083475A1 Novel heterocyclic compounds with anti-inflammatory activity
11/08/2001	WO2001083453A1 Novel substituted tricyclic compounds
11/08/2001	WO2001083452A1 Novel tricyclic compounds
11/08/2001	WO2001083438A2 New gamma selective retinoids
11/08/2001	WO2001083405A1 Process for the catalytic oxidation of hydrocarbons
11/08/2001	WO2001082923A1 Estrogen receptor modulators
11/08/2001	WO2001082920A2 Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist
11/08/2001	WO2001049657A8 2-`3-amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitors
11/08/2001	WO2001041760A3 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
11/08/2001	WO2001023352A3 Preparation of sulfonyl imine compounds
11/08/2001	US20010039355 One pot process
11/08/2001	US20010039348 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
11/08/2001	US20010038879 Solid delivery systems for aroma ingredients
11/08/2001	DE10021703A1 Continuous separation of mixtures containing tetrahydrofuran, gamma-butyrolactone and/or 1,4-butanediol, e.g. from maleic anhydride hydrogenation, uses partitioned or heat-coupled conventional distillation columns
11/08/2001	CA2407418A1 Novel heterocyclic compounds with anti-inflammatory activity
11/08/2001	CA2407189A1 New gamma selective retinoids
11/07/2001	EP1152000A1 Citalopram hydrobromide crystal and method for crystallization thereof
11/07/2001	EP1150966A1 Method for the preparation of 5-cyanophthalide
11/07/2001	EP1150960A1 Polymorphic crystalline forms of celecoxib
11/07/2001	EP1150959A1 Solid-state form of celecoxib having enhanced bioavailability
11/07/2001	EP1150948A1 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
11/07/2001	EP1150944A1 N2-phenylamidine derivatives
11/07/2001	EP0925273B1 Pharmaceutical composition containing 4-oxo-butynic acids
11/07/2001	CN1321158A Tricyclic delta 3-piperidines as pharmaceuticals
11/07/2001	CN1320599A Limited 9-cis-isotretinoins
11/07/2001	CN1320426A Compound for treatment of female sexual dysfuction
11/06/2001	US6313321 Process for preparing β-hydroxy-γ-butyrolactones and β-(meth)acryloyloxy-γ-butrolactones
11/06/2001	US6313318 Process for the preparation of α-methylene lactones
11/06/2001	US6313294 Solvent-free amidation reaction of molten secondary alkylenediamine and ester to form tertiary amide; one step; noncatalytic reaction
11/06/2001	US6313293 Preparation of amides and quinazoline derivatives
11/06/2001	US6313173 Glyoxylic acid amides
11/06/2001	US6313139 Administering benzylamine derivative for therapy of psychiatric disorder in mammals
11/06/2001	US6313132 Therapeutically active diarylpropylamines; their pharmaceutically acceptable salts; a method for their preparation and method for their use
11/06/2001	US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals
11/06/2001	US6313100 Antibacterial, antiprotozoa agents
11/02/2001	CA2343543A1 Citalopram hydrobromide crystal and method for crystallization thereof
11/01/2001	WO2001081333A2 Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes
11/01/2001	WO2001081332A2 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
11/01/2001	WO2001081330A2 Process and intermediates for making substituted aspartic acid acetals
11/01/2001	WO2001081289A1 Improved process for the preparation of 3,4-dihydroxybutanoic acid and salts and lactones derived therefrom
11/01/2001	WO2001080619A2 Pharmaceutical composition containing citalopram
11/01/2001	WO2001041762A3 Valdecoxib compositions
11/01/2001	WO2001041761A3 Valdecoxib compositions
11/01/2001	WO2001033966A3 Active ingredient combination having insecticidal and acaricidal characteristics
11/01/2001	WO2001030736A3 Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors
11/01/2001	US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001	US20010036924 Dietetics, immunomodulator, antiinflammatory agents
11/01/2001	US20010036652 Diels-Alder process; antitumor agents
11/01/2001	CA2402128A1 Process and intermediates for making substituted aspartic acid acetals
10/2001
10/31/2001	EP1149094A2 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors
10/31/2001	EP1149087A1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use
10/31/2001	EP1149085A1 Aminoalkylbenzofurans as serotonin (5-ht(2c)) agonists
10/31/2001	EP1149084A1 Method for producing l-ascorbic acid
10/31/2001	EP1149069A1 Phenylglycine derivatives
10/31/2001	EP1148940A1 Reactor module with contact tube bundle
10/31/2001	EP1148880A2 Methods for restoring and/or enhancing accommodation in pseudo phakia
10/31/2001	EP0929543B1 Herbicidal composition
10/31/2001	EP0888380B1 Process for alkylating and smiles rearrangement of hydroxy aromatics
10/31/2001	EP0876356B1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
10/31/2001	EP0717620B1 Substituted 2-aminotetralins
10/31/2001	CN1074013C 3-arylbenzofuranones as stabilisers and its use
10/31/2001	CN1073994C Novel processes for preparing ranitidine
10/31/2001	CN1073993C Process for preparing bis (ether anhybrides) using alkylamine derivaed bismides having low melting temperatures
10/31/2001	CN1073988C Substituted N-heteroaroylguanidin, preparation, pharmaceutical application and medicine containg same
10/30/2001	US6310222 Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
10/30/2001	US6310221 Methods for synthesis of substituted tetrahydrofuran compound
10/30/2001	US6310107 (+)-6-(4-biphenylyl)methoxy-2-(2-(n,n-dimethylamino)ethyl)tetr alin, or a salt is useful for inhibiting production and/or secretion of amyloid-beta protein
10/30/2001	US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001	US6310092 Treating systemic lupus, multiple sclerosis, rheumatoid arthritis, septic shock, erythema nodosum leprosy, septicemia, uveitis, adult respiratory distress syndrome or inflammatory bowel disease

1 ... 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 ... 472